Transcription Factors in Late Megakaryopoiesis and Related Platelet Disorders

Overview

Journal J Thromb Haemost

Publisher Elsevier

Specialty Hematology

Date 2013 Jan 15

PMID 23311859

Citations 46

Authors

M R Tijssen

C Ghevaert

Affiliations

Soon will be listed here.

Abstract

Cell type-specific transcription factors regulate the repertoire of genes expressed in a cell and thereby determine its phenotype. The differentiation of megakaryocytes, the platelet progenitors, from hematopoietic stem cells is a well-known process that can be mimicked in culture. However, the efficient formation of platelets in culture remains a challenge. Platelet formation is a complicated process including megakaryocyte maturation, platelet assembly and platelet shedding. We hypothesize that a better understanding of the transcriptional regulation of this process will allow us to influence it such that sufficient numbers of platelets can be produced for clinical applications. After an introduction to gene regulation and platelet formation, this review summarizes the current knowledge of the regulation of platelet formation by the transcription factors EVI1, GATA1, FLI1, NFE2, RUNX1, SRF and its co-factor MKL1, and TAL1. Also covered is how some platelet disorders including myeloproliferative neoplasms, result from disturbances of the transcriptional regulation. These disorders give us invaluable insights into the crucial role these transcription factors play in platelet formation. Finally, there is discussion of how a better understanding of these processes will be needed to allow for efficient production of platelets in vitro.

Citing Articles

Thrombocytopenia in dengue infection: mechanisms and a potential application.

Khazali A, Hadrawi W, Ibrahim F, Othman S, Nor Rashid N Expert Rev Mol Med. 2024; 26:e26.

PMID: 39397710 PMC: 11488332. DOI: 10.1017/erm.2024.18.

HOXD9 regulated mitophagy to promote endothelial progenitor cells angiogenesis and deep vein thrombosis recanalization and resolution.

Xiujin Z, Lili G, Jing F, Wenhai Y, Sikai L, Wan-Yin S Mol Med. 2024; 30(1):84.

PMID: 38867168 PMC: 11167931. DOI: 10.1186/s10020-024-00852-5.

Dachshund Homolog 1: Unveiling Its Potential Role in Megakaryopoiesis and Lethal Toxin-Induced Thrombocytopenia.

Lin G, Chang H, Lin W, Liou Y, Lai Y, Hsieh M Int J Mol Sci. 2024; 25(6).

PMID: 38542074 PMC: 10970148. DOI: 10.3390/ijms25063102.

Composition of thrombi in zebrafish: similarities and distinctions with mammals.

Griffin M, Dahlgren A, Nagaswami C, Litvinov R, Keeler K, Madenjian C J Thromb Haemost. 2023; 22(4):1056-1068.

PMID: 38160724 PMC: 11293624. DOI: 10.1016/j.jtha.2023.12.025.

Wnt/β-Catenin-Signaling Modulates Megakaryopoiesis at the Megakaryocyte-Erythrocyte Progenitor Stage in the Hematopoietic System.

Yalcin B, Macas J, Wiercinska E, Harter P, Fawaz M, Schmachtel T Cells. 2023; 12(23).

PMID: 38067194 PMC: 10706863. DOI: 10.3390/cells12232765.

References

Thon J, Italiano J . Platelet formation. Semin Hematol. 2010; 47(3):220-6. PMC: 2904625. DOI: 10.1053/j.seminhematol.2010.03.005. View

Dore L, Crispino J . Transcription factor networks in erythroid cell and megakaryocyte development. Blood. 2011; 118(2):231-9. PMC: 3138678. DOI: 10.1182/blood-2011-04-285981. View

Hamada T, Mohle R, Hesselgesser J, HOXIE J, Nachman R, Moore M . Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med. 1998; 188(3):539-48. PMC: 2212480. DOI: 10.1084/jem.188.3.539. View

De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P . Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost. 2007; 5(4):708-14. DOI: 10.1111/j.1538-7836.2007.02424.x. View

Shiraga M, Ritchie A, Aidoudi S, Baron V, Wilcox D, White G . Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling. J Cell Biol. 1999; 147(7):1419-30. PMC: 2174239. DOI: 10.1083/jcb.147.7.1419. View

Smith E, Thon J, Devine M, Lin S, Schulz V, Guo Y . MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation. Blood. 2012; 120(11):2317-29. PMC: 3447785. DOI: 10.1182/blood-2012-04-420828. View

Miyazaki R, Ogata H, Iguchi T, Sogo S, Kushida T, Ito T . Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol. 2000; 108(3):602-9. DOI: 10.1046/j.1365-2141.2000.01854.x. View

Ciovacco W, Raskind W, Kacena M . Human phenotypes associated with GATA-1 mutations. Gene. 2008; 427(1-2):1-6. PMC: 2601579. DOI: 10.1016/j.gene.2008.09.018. View

Ghevaert C, Salsmann A, Watkins N, Schaffner-Reckinger E, Rankin A, Garner S . A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia. Blood. 2007; 111(7):3407-14. DOI: 10.1182/blood-2007-09-112615. View

10.

Brown A, Martin J . The megakaryocyte platelet system and vascular disease. Eur J Clin Invest. 1994; 24 Suppl 1:9-15. DOI: 10.1111/j.1365-2362.1994.tb02419.x. View

11.

Shivdasani R, Rosenblatt M, Zucker-Franklin D, Jackson C, Hunt P, Saris C . Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995; 81(5):695-704. DOI: 10.1016/0092-8674(95)90531-6. View

12.

Leysi-Derilou Y, Duchesne C, Garnier A, Pineault N . Single-cell level analysis of megakaryocyte growth and development. Differentiation. 2012; 83(4):200-9. DOI: 10.1016/j.diff.2011.12.003. View

13.

Gekas C, Rhodes K, Gereige L, Helgadottir H, Ferrari R, Kurdistani S . Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis. Blood. 2009; 113(15):3461-71. PMC: 2945827. DOI: 10.1182/blood-2008-07-167577. View

14.

Makeev V, Lifanov A, Nazina A, Papatsenko D . Distance preferences in the arrangement of binding motifs and hierarchical levels in organization of transcription regulatory information. Nucleic Acids Res. 2003; 31(20):6016-26. PMC: 219477. DOI: 10.1093/nar/gkg799. View

15.

Nolis I, McKay D, Mantouvalou E, Lomvardas S, Merika M, Thanos D . Transcription factors mediate long-range enhancer-promoter interactions. Proc Natl Acad Sci U S A. 2009; 106(48):20222-7. PMC: 2779200. DOI: 10.1073/pnas.0902454106. View

16.

Shimizu S, Nagasawa T, Katoh O, Komatsu N, Yokota J, Morishita K . EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation. Biochem Biophys Res Commun. 2002; 292(3):609-16. DOI: 10.1006/bbrc.2002.6693. View

17.

Ng R, Gurdon J . Epigenetic inheritance of cell differentiation status. Cell Cycle. 2008; 7(9):1173-7. DOI: 10.4161/cc.7.9.5791. View

18.

Balduini A, Malara A, Pecci A, Badalucco S, Bozzi V, Pallotta I . Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano. J Thromb Haemost. 2008; 7(3):478-84. DOI: 10.1111/j.1538-7836.2008.03255.x. View

19.

Krumsiek J, Marr C, Schroeder T, Theis F . Hierarchical differentiation of myeloid progenitors is encoded in the transcription factor network. PLoS One. 2011; 6(8):e22649. PMC: 3154193. DOI: 10.1371/journal.pone.0022649. View

20.

Chen Z, Naveiras O, Balduini A, Mammoto A, Conti M, Adelstein R . The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood. 2007; 110(1):171-9. PMC: 1896110. DOI: 10.1182/blood-2007-02-071589. View